Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX · Real-Time Price · USD
142.44
+1.19 (0.84%)
Oct 9, 2026, 4:00 PM EDT - Market closed
Neurocrine Biosciences Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 3,374 | 2,861 | 2,355 | 1,887 | 1,489 | 1,134 |
Revenue Growth | 34.42% | 21.45% | 24.81% | 26.76% | 31.34% | 8.38% |
Gross Profit Gross Profit Growth | 2,176 | 1,793 | 1,590 | 1,282 | 1,002 | 791.1 |
Operating Income Operating Income Growth | 866 | 636.5 | 597 | 394.8 | 249 | 207.8 |
Net Income Net Income Growth | 705.5 | 478.6 | 341.3 | 249.7 | 154.5 | 89.6 |
Earnings Per Share EPS Growth | 6.82 | 4.67 | 3.29 | 2.47 | 1.56 | 0.92 |
EPS Growth | 101.21% | 41.95% | 33.20% | 58.33% | 69.56% | -77.89% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
INGREZZA INGREZZA Growth | 2,718 | 2,514 | 2,314 | 1,836 | 1,428 | 1,082 |
CRENESSITY CRENESSITY Growth | 570.3 | 301.2 | 1.7 | - | - | - |
ONGENTYS and Other Product ONGENTYS and Other Product Growth | - | 19 | 15.4 | 24.6 | 13.1 | 8.2 |
Royalties Royalties Growth | - | - | 18.6 | 21.2 | 22.3 | 22.3 |
Collaboration and Other Collaboration and Other Growth | - | - | 6.1 | 5.3 | 5.5 | 6.1 |
Revenue (Total) Revenue (Total) Growth | 3,374 | 2,861 | 2,355 | 1,887 | 1,489 | 1,134 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 389.8 | 1,480 | 1,076 | 1,032 | 989.3 | 711.3 |
Total Debt Total Debt Growth | 461.6 | 471.3 | 455.1 | 428.4 | 262.9 | 440.4 |
Net Cash (Debt) Net Cash Growth | -71.8 | 1,009 | 621 | 603.2 | 726.4 | 270.9 |
Net Cash Growth | - | 62.50% | 2.95% | -16.96% | 168.14% | -30.31% |
Net Cash Per Share Net Cash Per Share Growth | -0.69 | 9.84 | 5.99 | 5.97 | 7.34 | 2.77 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 898.1 | 782.7 | 595.4 | 389.9 | 339.4 | 256.5 |
Capital Expenditures CapEx Growth | -27.7 | -34 | -38.2 | -28.3 | -16.5 | -23.4 |
Free Cash Flow Free Cash Flow Growth | 870.4 | 748.7 | 557.2 | 361.6 | 322.9 | 233.1 |
Free Cash Flow Growth | 64.63% | 34.37% | 54.09% | 11.98% | 38.52% | 7.12% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 64.48% | 62.67% | 67.52% | 67.96% | 67.29% | 69.79% |
Operating Margin | 25.67% | 22.25% | 25.35% | 20.92% | 16.73% | 18.33% |
Pretax Margin | 27.87% | 24.66% | 20.63% | 17.60% | 14.37% | 8.95% |
Profit Margin | 20.91% | 16.73% | 14.49% | 13.23% | 10.38% | 7.90% |
FCF Margin | 25.80% | 26.17% | 23.66% | 19.16% | 21.69% | 20.57% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 20.88 | 29.55 | 40.49 | 51.85 | 74.32 | 90.18 |
Forward PE | 12.73 | 15.87 | 18.15 | 21.34 | 22.53 | 24.55 |
P/FCF Ratio | 16.63 | 18.89 | 24.80 | 35.80 | 35.56 | 34.66 |
PS Ratio | 4.29 | 4.94 | 5.87 | 6.86 | 7.71 | 7.13 |